Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jul 17;124(3):309-10.
doi: 10.1182/blood-2014-05-571646.

Triple jeopardy for Hodgkin lymphoma survivors?

Affiliations
Comment

Triple jeopardy for Hodgkin lymphoma survivors?

Lindsay M Morton. Blood. .

Abstract

In this issue of Blood, van Eggermond et al demonstrate that Hodgkin lymphoma survivors who develop a second malignancy have increased risk of developing yet a third malignancy.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interests.

Figures

None
Distribution of second and third malignancies, by type and gender, among 3122 Dutch patients who were originally diagnosed with HL by age 50 during 1965 to 1995, survived ≥5 years, and were followed through 2012.

Comment on

References

    1. van Eggermond AM, Schaapveld M, Lugtenburg PJ, et al. Risk of multiple primary malignancies following treatment of Hodgkin lymphoma. Blood. 2014;124(3):319–327. - PubMed
    1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014.
    1. Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin’s lymphoma. J Clin Oncol. 2007;25(12):1489–1497. - PubMed
    1. Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst. 2002;94(3):182–192. - PubMed
    1. Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290(4):465–475. - PubMed